Tingting Yao1,2, Zixiao Shi3, Jingwei Sun3, Yuhan Wang1,2, Haijian Zhou1,2, Yanru Chen4,5, Di Zhou3, Zhongqiu Lin1,2#, Yarong Liu3#
1Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, SunYat-sen University, 510120 Guangzhou, P.R. China
2Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 510120 Guangzhou, P.R. China
3Grit Biotechnology Co., Ltd. Shanghai, 201210 Shanghai, P.R. China
4Children’s Hospital of Fudan University at Xiamen, 361006 Xiamen, P.R. China
5Xiamen Children’s Hospital, 361006 Xiamen, P.R. China
#Correspondence:
Yarong Liu, Grit Biotechnology Co., Ltd. Shanghai, 1077 Zhangheng Road, PuDong, Shanghai, 201210, P.R. China
E-mail: yarong.liu@grit-bio.com
Zhongqiu Lin, Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, SunYat-sen University, 107 Yan Jiang West Road, 510120 Guangzhou, P.R. China, linzhongqiu@hotmail.com